Skip to main content

1 Result(s)

within Julia Degering Remove this filter

and

  1. Article

    Open Access

    Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study

    Epoprostenol AS (Veletri®), a thermostable epoprostenol formulation, provides better drug stability and improved clinical use compared to previous epoprostenol formulations. This study aims to expand clinical exp...

    Julia Degering, Benjamin Egenlauf, Satenik Harutyunova… in Respiratory Research (2023)

    Download PDF (996 KB) View Article